1. Home
  2. |Insights
  3. |Administration Ups the Ante on Federal Government's Use of Renewable Energy

Administration Ups the Ante on Federal Government's Use of Renewable Energy

Client Alert | 1 min read | 12.17.13

On December 5, the White House issued a memorandum directing federal agencies to sharply increase their use of renewable energy, from the current level of 7.5% of all energy consumed to a new goal of 20% by the year 2020. In what is likely to be good news for contractors in the emerging renewable energy field, under the White House guidance, agencies will increase their reliance on renewable sources by (i) installing agency-funded renewable energy on-site at federal facilities and retain renewable energy certificates; (ii) contracting for energy that includes the installation of a renewable energy project on-site at a federal facility or off-site from a federal facility and the retention of renewable energy certificates for the term of the contract; (iii) purchasing electricity and corresponding renewable energy certificates; and (iv) purchasing renewable energy certificates.


Insights

Client Alert | 9 min read | 10.21.26

Artificial Intelligence in Life Sciences: Reliability of AI-Generated Evidence in Drug Discovery and Development

The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .  ...